Anti-T cell monoclonal antibodies in vivo. I. Inhibition of delayed hypersensitivity but not cutaneous basophil hypersensitivity reactions

• Published in: The Journal of immunology (1950) Vol. 138; no. 8; pp. 2500 - 2506
• Main Authors: Sobel, RA, Hanzakos, JL, Blanchette, BW, Williams, AM, Dellapelle, P, Colvin, RB
• Format: Journal Article
• Language: English
• Published: Bethesda, MD Am Assoc Immnol 15.04.1987; American Association of Immunologists
• Subjects: Animals; Antibodies, Monoclonal - immunology; Basophils - immunology; Basophils - secretion; Biological and medical sciences; Guinea Pigs; Hypersensitivity, Delayed - immunology; Hypersensitivity, Delayed - pathology; Immunologic Capping; Immunopathology; Immunotherapy (general aspects); Lymph Nodes - pathology; Medical sciences; Mice; Skin - immunology; Skin - pathology; Skin Tests; Spleen - pathology; T-Lymphocytes - immunology; Rodentia; Delayed hypersensitivity; Monoclonal antibody; In vivo; Vertebrata; Mammalia; Guinea pig; Treatment; Jones Mote reaction; Animal; Immunotherapy; T-Lymphocyte; Inhibition
• ISSN: 0022-1767; 1550-6606
• DOI: 10.4049/jimmunol.138.8.2500

As part of a study of the therapeutic potential of anti-T cell monoclonal antibodies, we studied the biologic effects of 8BE6, a mouse anti-guinea pig (GP) pan-T cell monoclonal antibody, on blood and tissue T cells and on the prototypic T cell-mediated reactions, classic delayed hypersensitivity (DH) and cutaneous basophil hypersensitivity (CBH). 8BE6 reacts to a 68,000 m.w. protein probably homologous with human CD5 (T1) and murine Lyt-1. A single dose of 1.8 to 3.4 mg 8BE6 caused lymphopenia and greater than 90% depletion of 8BE6+ peripheral T cells 1 to 72 hr later, and a significant but lesser decrease of lymphocytes reacting with another pan-T cell monoclonal antibody (p less than 0.02 at 24 hr). Free serum 8BE6 was detected for up to 48 hr after administration. Immunoperoxidase stains of tissue revealed that lymphocytes in lymph nodes and spleen were coated with mouse immunoglobulin 1 hr after antibody treatment and displayed in situ capping. Subsequently, there was a loss of T cells in all tissues (spleen, lymph node, liver, and kidney) except the thymus, with normal 8BE6 antigen staining returning by 72 hr. Areas of induration of DH reactions to PPD were reduced in 8BE6-treated GP, compared with pretreatment reactions in the same GP or in control-treated GP (p less than 0.001 for both). The numbers of infiltrating T cells and fibronectin-receptor-positive macrophages were also reduced. In contrast, 8BE6 had no effect on CBH reactions, as judged by erythema and basophil counts in 1-micron sections, although fewer T cells were found in reaction sites. There were no differences in IgM, fibronectin, or Ia staining between 8BE6-treated GP and controls. In vivo administration of a single dose of anti-T cell monoclonal antibody results in a transient, highly specific depletion of T cell populations in peripheral blood and tissues except the thymus. This treatment inhibits DH but not CBH reactions by systemic and local depletion of T cells.